Five Minutes in Healthcare is where I discuss current events with some of the industry's most influential leaders, as well as innovative thinkers who are working to meet the challenges of the coronavirus pandemic.
Over the last week I have had the pleasure of speaking to Doug Beinborn, Peter Webner, Richard Fabian and Diku Mandavia. Each interview is approximately five minutes long, or a few minutes over five.
In this installment, I check in with Doug Beinborn, associate principal in strategic supplier partnerships with Vizient, to discuss implantable devices and the benefits of cardiac remote monitoring for patients, as well as healthcare providers.
This is a topic of special interest to Doug, and he has written about it in our magazine. In July he contributed a byline looking at how COVID-19 tipped the scales
in favor of remote cardiac monitoring.
Earlier, he provided an article provided a good introduction to remote cardiac monitoring
, which is a great place to start if you want to continue learning after watching the interview.
In this installment, I check in with Peter Webner, CEO of Zionexa US, a French-American biotech company producing a PET tracer for breast cancer called Cerianna, which was approved in May and will be launched in early 2020 in partnership with PETNET Solutions.
We discuss how the PET agent works, and how it is poised to improve breast cancer outcomes. Full prescribing information for Cerianna (fluoroestradiol F18) injection is available at https://www.cerianna.com/wp-content/uploads/2020/05/cerianna-prescribing-information.pdf
In this installment, I check in with Richard Fabian, president and CEO of Fujifilm Sonosite, and Diku Mandavia, CMO for Fujifilm Sonosite, to discuss the company's FDA approval for using point-of-care ultrasound for COVID-19, the diagnostic value it brings to the pandemic, and what the road to regulatory approval looked like.
I initially spoke to Dr. Mandavia back in May
about the role of point-of-care ultrasound in the pandemic, and since then the technology has continued to prove advantageous.
We hope you enjoy the videos. Please tell us what you think, and let us know who you would like to see interviewed next!